SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-006023
Filing Date
2020-02-24
Accepted
2020-02-24 16:05:24
Documents
4
Period of Report
2020-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eypt-8k_20200224.htm 8-K 37197
2 EX-1.1 eypt-ex11_6.htm EX-1.1 396782
3 EX-5.1 eypt-ex51_7.htm EX-5.1 15817
4 GRAPHIC g20kmxdqyfna000001.jpg GRAPHIC 2421
  Complete submission text file 0001564590-20-006023.txt   454612
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 20644297
SIC: 3826 Laboratory Analytical Instruments